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Abstract Outcome measures are considered the most important tools to monitor
patients’ outcome in both clinical and research settings. Measuring the clinical state of
patients is a fundamental part of our daily clinical practice and research that sometimes
is taken for granted. In peripheral neuropathies, there are many scales available, but most
of these are at the ordinal level. This paper will systematically address the types of scales
available (being nominal, ordinal, interval, or ratio data-based) in terms of their strengths
and weaknesses. The differences between classical test theory-based and modern test
method-based outcomemeasureswill be addressedwith emphasis on Raschmethodology.
Various steps will be highlighted as part of the evaluation and construction of outcome
measures using the Raschmethod, with the aim to increase the knowledge and utility of this
technique. We argue that Rasch-built outcome measures should be used for future studies
in neuromuscular disorders and their method of construction could be easily extrapolated
to other neurological illnesses.
Key words: classical test theory, item response theory, measurement, outcome measure,
Rasch
Introduction
Assessing outcome in clinical studies would be
much easier if there was a metric for every quality
of interest (e.g., mobility, fatigue, depression, pain,
daily/social functioning, etc) with a fixed unit through-
out the metric’s range such as when measuring height
or weight. Then, trial design and clinical follow-up stud-
ies would have been much easier, and this would have
facilitated the routine use of standardized outcome
measures. Unfortunately, most qualities of interest in
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the medical field are less easily measured and do not
have a fixed internationally standardized ruler for their
assessments. Surrogate outcome measures are often
applied and are considered the second best option
to collect information about a patient in both clinical
practice and research setting. Measurement is such a
fundamental part of our daily clinical activities that we
sometimes may take the construction and use of out-
come measures for granted. It appears as if we all are
constructing and using our own scales. As an example,
a review of 713 studies on (www.clinicaltrials.gov;
March 10, 2014; using the terms “peripheral neu-
ropathy” and “randomized”) showed 85% of used
outcome measures at the ordinal level of assessment,
despite the shortcomings of such scales that have
been addressed in the literature for decades (Stevens,
© 2015 Peripheral Nerve Society 260
Vanhoutte et al. Journal of the Peripheral Nervous System 20:260–268 (2015)
1946; Merbitz et al., 1989; DeVellis, 2006; Grimby
et al., 2012). Types of collected data should be part
of the educational arsenal for clinicians, increasing
their awareness about their (dis)advantages regarding
when and how they are used (Stevens, 1946). Also,
new methodological techniques for the development
of outcome measures, such as the Rasch model and
the item response theory (IRT) have been increasingly
recognized, although not generally applied (Rasch,
1960; Hays et al., 2000; Tennant and Conaghan, 2007).
A plausible explanation would be that these methods
appear to have a complex mathematical background,
and therefore less accessible to most physicians,
including neurologists. Nevertheless, the superiority
of modern clinimetric approaches compared with the
classical test methods is now established and there-
fore should be applied in future studies for designing
proper outcome measures (Stevens, 1946; Merbitz
et al., 1989; Svensson, 2001; DeVellis, 2006; Grimby
et al., 2012).
This paper has the following purposes: (1) to sys-
tematically address available types of scales related
to type of data collected, (2) to demonstrate the
differences between classical vs. modern test theo-
ries, emphasizing the advantages of modern clinimet-
ric methods, and (3) to highlight the various steps
needed in evaluating and constructing outcome mea-
sures using the Rasch method, which is applied as an
example in the inflammatory neuropathy field and may
be extrapolated to other neurological areas as well.
Measurement and Types of Data
Measuring the height of a patient is generally per-
formed without any difficulty, using a ruler with a fixed
unit (in Europe: centimeters, in Anglo-Saxon commu-
nity: foot/inch; see Fig. S1A). However, in health care,
it is often necessary to measure qualities such as pain,
fatigue, or disability, where there is no ruler with a fixed
unit available. Such qualities are nevertheless generally
assessed using constructed surrogate outcome mea-
sures that are often composed of a set of items or
questions (Fig. S1B).
In science, “measure” involves numbers that can
be used in calculations. Even after multiplying and
dividing, the numbers should maintain their values
(“known unit”). Most clinical trials performed thus
far in inflammatory neuropathies have collected raw
data from a set of items or questions that have not
been measured in this way (Tesio, 2003; Hobart et al.,
2007). Whether the collected numbers can be used in
calculations depends on the type of data in the scale.
For example, data at the nominal level consist of num-
bers or labels with unknown magnitude. It is therefore
not possible to determine which category is greater or
less than another. Examples of these are sex, blood
type, religion, etc. Data measured at the ordinal level
can be ordered or ranked, but the difference between
the categories is unknown or unequal (e.g., level of
disability). Thus by ranking data the only information
that can be obtained is whether a value is greater or
less relative to the other. As the distance between
the numbers assigned to the different categories is
highly unlikely to be equal, sum scores cannot be
used. Also, it is not possible to compare different
multi-item composite scales measuring the same
trait (Stevens, 1946; Merbitz et al., 1989; Tesio, 2003;
DeVellis, 2006; Grimby et al., 2012). For example,
the overall disability sum score (Merkies et al.,
2002) and the Rankin disability scale (van Swieten
et al., 1988) are both disability scales, but their out-
comes cannot be compared. In addition, using the
Medical Research Council (MRC) grading system to
examine strength at bedside assumes a fixed unit
for the assessment of strength in the various muscle
groups (Medical Research Council, 1943; Vanhoutte
et al., 2012). However, the MRC grading system is
a descriptive categorical measure; thus, the data
collected are at the ordinal level with no intrinsic
numerical value. Even if there was a fixed unit, one
cannot understand how a patient with an MRC grade
4 for the quadriceps muscle, is able to push 53 pounds
during gym exercise, while the same patient with an
MRC grade 5 (normal strength) for the wrist extensors
only lifts 8 pounds with this group of muscles. The
inequality of the MRC grading system has already
been extensively demonstrated by comparing the
distribution of the grades with a dynamometer (data
at the ratio level) for assessing strength (van der
Ploeg et al., 1984; Brandsma et al., 1995; Cuthbert and
Goodheart, 2007; MacAvoy and Green, 2007; Merlini,
2010).
When the distance between two successive cate-
gories is known, measurement is at the interval level
and meaningful calculations can be made. Depend-
ing on how the response options are ordered (e.g.,
a higher score indicate less disability or vice versa),
a higher response score may indicate a lower/bigger
effect of that particular item on the total score. When a
non-arbitrary zero value indicating the lack of whatever
you try to measure is present, a ratio scale is created
(e.g., length and weight). Conventional (or parametric)
statistics (e.g., t-test) can only be applied at the inter-
val or ratio level, where a known unit of difference is
present between two successive categories (Bond and
Fox, 2007).
Physicians and researchers should be aware that
there are four levels of assessing outcome: the level of
pathology, impairment, activity and participation, and
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the concept of quality of life (Aaronson, 1988; World
Health Organization, 2001). Outcomemeasures should
solely represent one of these levels using only items
at that particular domain, since the findings at one
domain, for example impairment measures (such as
weakness) may be correlated with activity limitations
in daily and social functioning (weakness leading to
disability) (Aaronson, 1988; World Health Organization,
2001; Merkies et al., 2003). Having items representing
various levels of assessing outcome may inflate the
final sum score and provide improper results (Tennant
and Conaghan, 2007).
Models to Create Outcome Measures
A mathematical model is required to assess a
particular patient’s quality of interest (e.g., fatigue,
depression, etc). Such a model is a mathematical
representation of reality and can be used to create
a surrogate outcome measure in the absence of
a known ruler with a fixed unit (Hobart and Cano,
2009). The classical test theory (CTT) is the most
widely used model, based on the assumption that
the true score is the sum of the obtained score (raw
data) and random error (DeVellis, 2006; Hobart and
Cano, 2009). However, the magnitude of random error
is unknown. Outcome measures based on the CTT
are always ordinal in nature and have limitations as
discussed previously (Merbitz et al., 1989; DeVellis,
2006; Grimby et al., 2012). In brief, items as part
of a CTT ordinal-based metric are arbitrarily taken
generally using a Likert-type form of response options;
in addition, it is assumed that all parts of such a metric
have equal contribution to the scale, which is highly
unlikely. The various weights of each item are generally
unknown. Often, sum scores have been constructed
assuming linearity of such a measure, which is also
highly unlikely (Merbitz et al., 1989; Stucki et al., 1996;
DeVellis, 2006; Hobart and Cano, 2009; Grimby et al.,
2012). Thus, a difference in the scores will not have
the same meaning throughout the range of the scale
of interest. These observations may lead to wrong
conclusions in intervention trials, such as false positive
or negative results.
There are two modern techniques to transform
outcome measures to the interval level: the Rasch
model and the IRT, which have the same mathematical
background. The IRT approaches include additional
model parameters to reflect the patterns observed in
the data (Wright and Mok, 2004; Bond and Fox, 2007;
Hobart et al., 2007). On the other hand, according to
the Rasch approach, the data should fit the Rasch
model, before any reliable claim about the presence
of a trait can be made. Therefore misfitting responses
require further examination to explore the reason for
themisfit, andmay be excluded from the data set if one
can explain substantively why they do not address the
latent trait (Rasch, 1960; Massof, 2002; Tesio, 2003;
Hobart and Cano, 2009). When the expectations of
the model are fulfilled, interval measurement can be
obtained. Rasch analysis should be used when there
is a need to use a set of items in order to create
sum scores. In scale development, Rasch can be used
to create a new unidimensional outcome measure
free from item bias. Also, the scientific properties
of existing scales can be examined using Rasch and
item banks can be constructed (Pallant and Tennant,
2007; Tennant and Conaghan, 2007). Another major
advantage of the Rasch model is that it overcomes the
problem of missing data by providing calculations of
these as part of the modeling (Andrich and Sheridan,
2004; Wright and Mok, 2004).
Background of the Rasch Model
In 1960, Georg Rasch stated that “a person having
a greater ability than another person should have the
greater probability of solving any item or type in ques-
tion, and similarly, one item being more difficult than
another means that for any person the probability of
solving the second item is the greater one” (Rasch,
1960). In other words, patients with a higher ability
(less ill) should have a greater chance of obtaining a
higher score on any item/task of interest. Thus, the
probability of confirming an item depends on the dif-
ference between the ability (“quality of interest”) of
the person and the difficulty of the item (Rasch, 1960;
Wright and Mok, 2004; Tennant and Conaghan, 2007).
For example, a patient with severe disability due to
chronic inflammatory demyelinating polyradiculoneu-
ropathy is expected to have more difficulty climbing
a flight of stairs than a less disabled patient (van Nes
et al., 2011).
On the basis of the so-called Guttman scaling, peo-
ple can be arranged in such a manner that if a person is
able to perform a particular task, this individual should
also have a high probability to complete tasks with
a lower rank order. Accordingly, items can be ranked
frommost easy to most difficult (Fig. 1) (Altman, 1991).
Thereafter, both the “person ability” and the “item
difficulty” can be placed on the same mutual ruler
(Fig. 2).
After ordering the obtained ordinal data into a
Guttman table, the model subsequently estimates
the person’s ability and item difficulty separately and
independently from each other and expresses these
as a log odds ratio or Logits (Appendix S1; Smith and
Smith, 2004; Bond and Fox, 2007; Hobart and Cano,
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Figure 1. Example of a Guttman scaling. The Guttman scale orders the difficulty of items and ability of persons in a matrix
(A). An example of a Rasch-built scale is provided in (B); the inflammatory-Rasch-built Overall Disability Scale showing the item
“able to wash your face” being one of the easiest items compared to the “ability to walk a flight of stairs” (van Nes et al.,
2011).
Figure 2. Interval ruler. Using interval instead of ordinal mea-
sures provides a true reflection of disease effect, differences
between individuals and groups, and treatment effects. The
corresponding weights (“location”) of the items and patients
also are calculated by themodel depending on the interaction
between the items and the patients.
2009). After fulfilling additional requirements of the
Rasch model, interval measurement on a logits scale
can be obtained from ordinal measures (Tennant and
Conaghan, 2007).
Rasch Model Requirements
To obtain a scale at the interval level, all items
and persons as part of the model need to fulfill
several Rasch methodology requirements, or check-
points. Most requirements of the Rasch model are
based on the assumption that the obtained raw data
should not deviate significantly from the ideal situa-
tion, that is, what was estimated by the Rasch model
(Bond and Fox, 2007; Tennant and Conaghan, 2007;
Hobart and Cano, 2009). The Rasch unidimensional
measurement model (RUMM) is a computer program
that can be used to check whether the data fit the
model expectations. Items or patients not fulfilling
these requirements should be removed or subjected
to re-adjustments to fit the model’s requirements
(Andrich et al., 2003; Andrich and Sheridan, 2004). The
following steps are checkpoints that should be accom-
plished to achieve model fit.
Parameterization of the Rasch model
The Rasch model contains several specifications
and which one should be used depends on the number
of response options. When a set of items contain only
two response options, the dichotomous model is used
(Tennant and Conaghan, 2007). However, when more
than two response options are present a “threshold”
parameter is applied (Fig. 3A) (Tennant et al., 2004). A
threshold is the point between two adjacent categories
where either response is equally probable. The partial
credit model is an extension of the threshold parameter
model and makes no assumptions about the equality
of threshold locations relative to each item (Tennant
et al., 2004). The partial credit model is used as
default in RUMM. However, the likelihood ratio test can
be performed to determine whether the rating scale
model could be used (Andrich et al., 2003).
Targeting and person–item distribution
Rasch always places the mean of the items around
zero logits and this represents the average difficulty
of a scale. The mean of persons can be compared to
the item mean of zero and this provides an indication
of the targeting of the scale. When the persons
mean deviates from zero, the targeting might be at
risk. If this value is positive, the items may have
been too easy for the person, and a negative value
suggests the opposite (Tennant and Conaghan, 2007).
Furthermore, the location of the persons (showing their
degree of ability [degree of illness]) should be wide
enough. This can be examined using the item-person
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Figure 3. Examples of ordered and disordered thresholds. If patients cannot discriminate properly between the response
options, “reversed or disordered thresholds” will occur. An example of ordered thresholds is given in (A), whereas (B) shows
disordered thresholds. MRC. Medical Research Council; NIS, neuropathy impairment scale.
distribution. In the ideal situation, the responses should
preferably have no floor or ceiling effects. Items and
persons should be distributed in such a way that the
items can be distinguished among persons. Persons
in the middle of the test have the smallest error of
measurement (Andrich and Sheridan, 2004).
Reliability
Internal reliability can be estimated, based on the
person separation index (PSI). The PSI provides an
indication about the ability to discriminate between
different groups. A value exceeding 0.7 indicates the
ability to identify at least two groups of patients (Pallant
and Tennant, 2007).
Sample size
Preferably, a minimum of 150 patients, and prefer-
ably 250, would be required to have 99% confidence so
that the item calibrations remain stable within 0.5 log-
its (Linacre et al., 1994). If necessary, data assessed a
second time may be stacked to the first data records
to increase the sample size that is needed for a more
robust outcome measure model construction, hereby
controlling for time-factor as possible bias (Wright,
2003).
Unidimensionality
Although human behavior is complex in nature,
measurement requires that only one aspect at the time
is being measured. The Rasch model requires that all
items summed together form a unidimensional out-
come measure. For example, when assessing levels
of disability, there should be no questions about other
aspects, such as fatigue or quality of life. Exploring a
wider range of experiences does not only add infor-
mation about the trait of interest (e.g., disability), but
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also addresses other aspects of behavior and thereby
would create multidimensional scales. The outcome of
these scales is not interpretable as it does not only
provide (an unknown amount of) information about the
latent trait, but also an unknown amount of information
about other aspects. When the response to an item
depends on a factor other than the person’s ability, uni-
dimensionality is violated (Pallant and Tennant, 2007).
Fit analysis
The method requires that all raw data do not
deviate significantly from the model’s expectation. For
example, patients who are able to perform “difficult”
but not “easy” items are reason for concern. Item
fit also needs to be examined. The Rasch model
estimates of person ability and item difficulty represent
the ideal situation where the data are forced to be
linear and unidimensional. There are several statistics
available to determine whether the raw data deviate
from the expected “ideal” situation. Fit statistics,
considered as forms of checkpoints, give an indication
whether the quality is sufficient to allow the output to
be interpreted as an interval measurement (Bond and
Fox, 2007; Pallant and Tennant, 2007). When targeting
is not optimal, fit statistics should be interpreted
with some caution. There are two general categories
for detecting misfit: overall misfit, using the entire
response matrix, and the individual fit examining all
items and all persons individually (Tennant et al., 2004;
Pallant and Tennant, 2007).
Overall fit statistics
In RUMM, a summary of statistics is provided.
Three overall fit statistics are generally considered.
Item fit statistic places the mean item difficulty arbitrar-
ily at 0 logits. The person mean is estimated in relation
to the item difficulty. Residuals are calculated using the
difference between what is observed (raw data and
responses) and what is expected by the model (the
probabilities). For both the persons and the items, the
overall mean residual values can be calculated. Residu-
als are transformed into a z-score, indicating the num-
ber of SD a given observation is above or below the
mean (Tesio, 2003; Tennant et al., 2004; Pallant and
Tennant, 2007). When data fit the model, a mean of 0
and an SD of 1 can be expected. As a rule of thumb, a fit
residual SD greater than 1.4 indicatesmisfit (Pallant and
Tennant, 2007; Tennant and Conaghan, 2007). The next
overall statistic is the item–trait interaction statistic
that reflects the fit of the observed data to the model’s
estimates and is represented by the chi-square. It is
calculated from a comparison of the observed overall
performance of each trait-group (class interval) on the
itemwith its expected performance. Therefore, it gives
an indication of the degree of invariance of each of the
items and how the items function across the trait. A
significant chi-squaremeans overall itemmisfit, indicat-
ing multidimensionality (Pallant and Tennant, 2007).
Individual person and item fit
Besides the overall fit residuals, the individual
residuals can be calculated. Although the residual can-
not achieve zero, individual residual values outside±2.5
should be examined. A significant item chi-square indi-
cates significant deviation of the model. Item fit resid-
uals with high positive values are underdiscriminating
and suggest poor fit to the model. High negative resid-
uals are overdiscriminating and do not add extra infor-
mation. The individual item chi-square should not be
significant; as a significant chi-square indicates that the
item deviates from the model. Items or persons show-
ing misfit to the model should be examined. As a last
solution, items or persons can be deleted to improve
the scale construct (Pallant and Tennant, 2007; Tennant
and Conaghan, 2007).
Working of response categories
For polytomous data, the point between two adja-
cent response categories where the probability on
either response is equal is referred to as a threshold
(Fig. 3A). Disordered thresholds are sources of misfit
and occur when respondents use the response options
inconsistently (Fig. 3B). Persons can experience diffi-
culties discriminating consistently between response
options, when the labeling of the options is confusing,
open to misinterpretation, or when there are too many
options. Consistently means that the scoring options
of an item should increase systematically in a logical
and ordered manner and that a patient with a higher
ability should have a higher probability of getting a bet-
ter score in response to a single item. In general, it has
been argued that adults are not able to discriminate
betweenmore than four response options (Penta et al.,
2001). Disordered thresholds usually can be resolved
by collapsing categories. The number of patients in
each class interval should always be checked before
collapsing categories (Pallant and Tennant, 2007).
Differential item functioning
Differential item functioning (DIF) occurs when per-
sons in different subgroups (e.g., based on age, sex,
nationality, or underlying disorder) with equal ability lev-
els respond differently to an individual item. In the item
characteristic curve, the proportion of persons with
the same ability who confirm a particular item should
remain the same irrespective of any subgroup (Fig. 4A).
Items that do not yield the same item response func-
tion for two ormore groups display DIF (Fig. 4B) and are
violating the requirement of unidimensionality (Holland
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Figure 4. Differential item functioning (DIF). A scale should always work in the same way irrespective of which personal factor
(e.g., sex and country) is being examined. If this is the case, there is no DIF present (A). If patients with equal ability levels
respond systematically differently to an item, this item shows DIF and will violate the requirement for unidimensionality (B).
ICC, item characteristic curve.
et al., 1993; Tennant et al., 2004; Pallant and Tennant,
2007; Tennant and Conaghan, 2007).
There are two types of DIF: uniform and
non-uniform DIF. Uniform DIF occurs when the per-
sons in a particular subgroup respond consistently
and systematically differently, across the whole range
of the ability. Non-uniform DIF occurs when the dif-
ference varies across the ability levels. The statistical
test used for detection of DIF is an ANOVA of the
person–item deviation residuals with person factors
(e.g., age, sex, nationality, and disease duration) and
class intervals (e.g., group along the trait) as factors.
A summary of DIF is presented in the ANOVA table of
the person–item deviation residuals for each person
factor and class interval using the RUMM program.
Uniform DIF is visualized by a significant p-value on DIF
(item) effect, and non-uniform DIF by a significant item
by class interval p-value. With many tests of fit, some
will be significant just by chance; therefore, the Bonfer-
roni correction should be applied (Bland and Altman,
1995). When DIF is present in one group, artificial DIF
can appear in another group (Brodersen et al., 2007;
Andrich and Hagquist, 2012). If there is more than one
item showing DIF, the first thing to do is to split or
remove the item with the highest mean square, as this
will be the item displaying real DIF. Items displaying
artificial DIF should then disappear. Uniform DIF can
be resolved by splitting the item on person factor, or
by removing the item. For non-uniform DIF removal of
the item is often the only solution (Pallant and Tennant,
2007; Tennant and Conaghan, 2007).
Response dependency
The reliability can be inflated and the final scale’s
score can be forced in a particular direction when the
responses to items in an outcome measure are related
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to each other. In other words, affirming one item should
not automatically lead to the affirmation of another item
(e.g., a person stating that he is able to walk 1 km will
also be able to walk 100m). Local dependency can
be discovered through the residual correlation matrix.
Combining items in a subtest or eliminating items
solves the problem of local dependency and improves
model fit. Residual correlations above 0.3 need to be
resolved by combining the items in a subtest or by
deleting items (Tennant and Conaghan, 2007).
Responsiveness
Sensitivity to change or responsiveness is defined
as the ability of an instrument to detect important
changes over time and is a required quality for any
instrument to be used in clinical trials and research
designs. The sensitivity to change can be tested
according to both group-level and individual-level
approaches. The group-level approach consists of
computing different responsiveness indices in groups
of patients (paired t-test, effect size, and standardized
response mean). The individual approach consists of
taking into account the SE of measurement associ-
ated with the patient’s score obtained during both
evaluations. It is important to underline here that any
Rasch-built scale provides the individual’s measures
with associated SE of measurement. A statistic for
each patient can be computed to test the extent
to which their personal score has changed. The
individual-level approach presents a considerable
advantage compared with the group-level approach
as it can report whether the score level of a partic-
ular patient has significantly improved or decreased.
Indeed, meaningful change for groups of patients
may not have the same significance for individuals.
Consequently, the individual-level approach provides
clinicians an alternative method of drawing conclu-
sions from group results to individuals. Results can
henceforth be interpreted patient by patient.
Conclusion
The Rasch model can be seen as the ideal
response pattern, where persons with high abilities
should have a higher probability of receiving a better
score on any item compared to persons with a lower
ability. Also, any person should always have a greater
probability of receiving a higher score on an easier
item than on a more difficult one. In the model, person
ability and item difficulty are estimated separately. The
difference between the ability and the difficulty should
not deviate significantly from the model and various
checkpoints are being used to monitor this. All data
should fulfill the Rasch model’s expectations such as
good item and person statistical fit, threshold ordering,
no item bias or local dependency and demonstrating
unidimensionality. Only after these criteria are satisfied
will the measurement be at the interval level on a log-
its scale and suitable for conventional statistics. Only
then, meaningful sum scores and changes in scores
can be measured properly.
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